Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Luther

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1990
Clinical pharmacology of enalkiren, a novel, dipeptide renin inhibitorH N Glassman, H D Kleinert, R S Boger, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1986
Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapyR R Luther, H N Glassman, W D Sperzel, et al.
American Journal of Hypertension|July 20, 1999
Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crisesS Oparil, S Aronson, G M Deeb, et al.
The American Journal of Cardiology|December 1, 1990
Effects of renin inhibition in systemic hypertensionP W Anderson, Y S Do, M Schambelan, et al.
Critical Care Medicine|October 3, 1999
The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjectsV S Mathur, S K Swan, L J Lambrecht, et al.
Journal of Clinical Pharmacology|October 1, 1987
Pharmacologic effects of A-49816, a new high-ceiling diureticR R Luther, G L Ringham, F J Steinberg, et al.
American Journal of Hypertension|October 6, 1999
Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effectsA A Taylor, A M Shepherd, W Polvino, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1988
Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activityH D Kleinert, D Martin, M A Chekal, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1998
Peripheral versus central potencies of N-type voltage-sensitive calcium channel blockersY X Wang, S Bezprozvannaya, S S Bowersox, et al.
Regional Anesthesia and Pain Medicine|June 2, 2000
Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative painP G Atanassoff, M W Hartmannsgruber, J Thrasher, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Cardiovascular Pharmacology|January 1, 1990
Clinical pharmacology of enalkiren, a novel, dipeptide renin inhibitorH N Glassman, H D Kleinert, R S Boger, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1986
Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapyR R Luther, H N Glassman, W D Sperzel, et al.
American Journal of Hypertension|July 20, 1999
Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crisesS Oparil, S Aronson, G M Deeb, et al.
The American Journal of Cardiology|December 1, 1990
Effects of renin inhibition in systemic hypertensionP W Anderson, Y S Do, M Schambelan, et al.
Critical Care Medicine|October 3, 1999
The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjectsV S Mathur, S K Swan, L J Lambrecht, et al.
Journal of Clinical Pharmacology|October 1, 1987
Pharmacologic effects of A-49816, a new high-ceiling diureticR R Luther, G L Ringham, F J Steinberg, et al.
American Journal of Hypertension|October 6, 1999
Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effectsA A Taylor, A M Shepherd, W Polvino, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1988
Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activityH D Kleinert, D Martin, M A Chekal, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1998
Peripheral versus central potencies of N-type voltage-sensitive calcium channel blockersY X Wang, S Bezprozvannaya, S S Bowersox, et al.
Regional Anesthesia and Pain Medicine|June 2, 2000
Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative painP G Atanassoff, M W Hartmannsgruber, J Thrasher, et al.
Pageof 5